Cart
sales@molnova.com
PARP10-IN-3
CAS No. 2225800-19-9
PARP10-IN-3( —— )
Catalog No. M36090 CAS No. 2225800-19-9
PARP10-IN-3 is a potent and selective mono-Adp-ribotransferase PARP10 inhibitor that inhibits human PARP10 (IC50:480 nM). PARP10-IN-3 also inhibited human PARP2 and human PARP15 with IC50 values of 1.7 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 46 | Get Quote |
|
| 10MG | 77 | Get Quote |
|
| 25MG | 150 | Get Quote |
|
| 50MG | 242 | Get Quote |
|
| 100MG | 377 | Get Quote |
|
| 500MG | 860 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePARP10-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionPARP10-IN-3 is a potent and selective mono-Adp-ribotransferase PARP10 inhibitor that inhibits human PARP10 (IC50:480 nM). PARP10-IN-3 also inhibited human PARP2 and human PARP15 with IC50 values of 1.7 μM.
-
DescriptionPARP10-IN-3 is a selective mono‐ADP‐ribosyltransferase PARP10 inhibitor with an IC50 of 480 nM for human PARP10. PARP10-IN-3 reveals potent inhibition on PARP2 and PARP15 with IC50s of 1.7 μM for human PARP2 and human PARP15, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225800-19-9
-
Formula Weight256.26
-
Molecular FormulaC14H12N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (195.11 mM; Ultrasonic (<60°C)
-
SMILESO(C1=CC(C(N)=O)=CC=C1)C2=CC=C(C(N)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Patricia Korn, et al. Evaluation of 3- and 4-Phenoxybenzamides as Selective Inhibitors of the Mono-ADP-Ribosyltransferase PARP10. ChemistryOpen. 2021 Oct;10(10):939-948.?
molnova catalog
related products
-
WAY-620473
WAY-620473 is a potent PARP-1 inhibitor with antitumor activity and alters eukaryotic lifespan.
-
Fluzoparib
fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR)-deficient cells.?
-
Venadaparib
Venadaparib (IDX-1197) is a potent, selective and orally active PARP inhibitor with IC50s of 1.4 nM and 1.0 nM for PARP1 and PARP2, respectively.
